GeneDx Holdings Corp.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-17.7M | $-63.3M | $-17.7M | $-7.6M | $10.8M | $-6.5M | $5.4M | $-8.3M |
| Depreciation & Amortization | $3.1M | $2.7M | $2.7M | $2.4M | $2.3M | $2.2M | $2.0M | $2.4M |
| Depreciation | $3.1M | $2.7M | — | — | $2.3M | $2.2M | — | $600.0K |
| Amortization | $3.6M | $4.1M | — | — | $3.9M | $3.5M | — | — |
| Stock-Based Compensation | $6.3M | $9.0M | $9.8M | $10.6M | $7.8M | $4.0M | $2.8M | $3.6M |
| Net Cash from Operating Activities | $-29.0M | $-32.4M | $-3.1M | $15.8M | $10.4M | $10.2M | $-3.2M | $-4.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $10.1M | $6.5M | $4.3M | $6.2M | $2.4M | $6.1M | $3.1M | $646.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-5.6M | $-17.3M | $-11.1M | $-4.7M | $-36.4M | $-9.4M | $-519.0K | $-7.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.0M | $38.6M | $23.2M | $10.8M | $346.0K | $13.7M | $31.0M | $14.0M |
| Net Change in Cash | $-33.6M | $-11.1M | $9.0M | $21.8M | $-25.6M | $14.5M | $27.3M | $1.8M |
| Free Cash Flow | $-39.1M | $-38.9M | $-7.4M | $9.6M | $8.1M | $4.1M | $-6.2M | $-5.0M |